Loading...
•
Sep 30, 2022
Pediatrix Q3 2022 Earnings Report
Pediatrix reported third quarter earnings, reflecting operational challenges in billing and collections and modest headwinds in volumes and payor mix.
Key Takeaways
Pediatrix Medical Group reported a net revenue of $490 million and an EPS of $0.35 for the third quarter of 2022. The company's operating results were impacted by challenges in billing and collections, as well as headwinds in volumes and payor mix. Adjusted EBITDA was reported as $58 million.
Net revenue was $490 million.
Income from continuing operations was $29 million.
Adjusted EBITDA was $58 million.
Adjusted EPS from continuing operations was $0.40.
Forward Guidance
Pediatrix anticipates that its 2022 Adjusted EBITDA will be in a range of $240 million to $245 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...